Conference Dates: November 14-15, 2007
Conference Location: Newark, New Jersey
Sponsoring Group: Healthcare Education Services
Conference Web Page URL: http://www.healthtech.com/Healthcare_education/hema_malignancies/Index.asp
Topics Covered: This course reviews the hematological system and provides an overview on the spectrum of hematological cancers. The pathophysiology of hematological malignancies such as leukemias, lymphomas and myeloma are discussed along with their common treatments such as high dose chemotherapy and total body irradiation. The issues and complications of bone marrow and stem cell transplant will be reviewed. Matters relating to clinical trial issues including ethical considerations and FDA directives will be examined. Case studies and open discussion will form an integral part of the program.
Who Should Attend: medical and non-medical staff within the pharmaceutical industry
Registration Information: Online: http://www.healthtech.com/Healthcare_education/hema_malignancies/Index.asp Call: 781-972-5486
Conference Fees: $2673
Continuing Education: No
Feb 25, 2011 - The risk of pulmonary embolism is significantly higher for outpatients with central nervous system, pancreatic, upper gastrointestinal, and lung/pleural malignancies, and lower for hematological and breast malignancies, according to a study published online Feb. 11 in Cancer.
Feb 25, 2011
Dec 8, 2010